Moreover, EGCG has been proved to have inhibitory properties on cell proliferation of breast and head and neck squamous cell carcinomas (HNSCC) by suppressing the activity of EGFR, signal transducer and activator of transcription 3 (STAT3), Akt and c-fos [41,42]. Here, FOS is linked to head and neck squamous cell carcinoma.